OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong · Delayed Price · Currency is HKD 4.035
-0.020 (-0.49%)
Aug 21, 2026, 3:59 PM HKT
HKG:6929 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 195.61 | 180.45 | 164.1 | 153.87 | 136.82 | 116.46 | |
Revenue Growth | 15.93% | 9.97% | 6.65% | 12.46% | 17.48% | 31.64% |
Cost of Revenue | 61.42 | 58.02 | 49.63 | 47.37 | 44.37 | 35.29 |
Gross Profit | 134.19 | 122.43 | 114.47 | 106.5 | 92.46 | 81.17 |
Selling, General & Admin | 73.35 | 67.38 | 62.7 | 54.84 | 55.13 | 50.06 |
Research & Development | 15.67 | 15.73 | 17.05 | 14.38 | 14.11 | 12.15 |
Other Operating Expenses | -0.78 | -0.69 | -0.44 | -2.14 | -0.92 | -1.4 |
Operating Expenses | 89.01 | 83.09 | 79.65 | 67.14 | 68.57 | 60.7 |
Operating Income | 45.18 | 39.34 | 34.82 | 39.36 | 23.89 | 20.48 |
Interest Expense | -0.19 | -0.17 | -0.22 | -0.13 | -1.46 | -5.61 |
Interest & Investment Income | 7.47 | 8.86 | 11.92 | 10.67 | 2.39 | 0.01 |
Earnings From Equity Investments | -0.84 | -1.32 | -1.51 | -0.84 | -0.2 | -0.21 |
Currency Exchange Gain (Loss) | -0.77 | 0.78 | -0.71 | -0.36 | -0.97 | -0.9 |
Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0 | -0.01 | -0.01 | -0 |
EBT Excluding Unusual Items | 50.83 | 47.47 | 44.3 | 48.69 | 23.65 | 13.77 |
Impairment of Goodwill | - | - | -1.57 | - | - | - |
Gain (Loss) on Sale of Investments | -0.17 | -0.24 | -0.28 | 0.98 | -1.49 | -0.05 |
Gain (Loss) on Sale of Assets | -0.1 | -0.1 | -0.01 | -0.05 | -0.03 | -0.08 |
Asset Writedown | - | - | - | - | -0.34 | - |
Other Unusual Items | -0.05 | -0.05 | -0.03 | 0.01 | 0 | -14.96 |
Pretax Income | 50.52 | 47.09 | 42.41 | 49.63 | 21.79 | -1.32 |
Income Tax Expense | 6.71 | 5.05 | 2.56 | 4.56 | 3.3 | 3.13 |
Earnings From Continuing Operations | 43.81 | 42.03 | 39.85 | 45.07 | 18.49 | -4.44 |
Minority Interest in Earnings | -0.12 | -0.13 | -0.13 | - | - | - |
Net Income | 43.68 | 41.9 | 39.72 | 45.07 | 18.49 | -4.44 |
Net Income to Common | 43.68 | 41.9 | 39.72 | 45.07 | 18.49 | -4.44 |
Net Income Growth | 7.40% | 5.49% | -11.88% | 143.76% | - | - |
Shares Outstanding (Basic) | 823 | 824 | 826 | 828 | 583 | 577 |
Shares Outstanding (Diluted) | 826 | 826 | 826 | 833 | 776 | 577 |
Shares Change | 0.03% | -0.09% | -0.80% | 7.29% | 34.58% | - |
EPS (Basic) | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 | -0.01 |
EPS (Diluted) | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 | -0.01 |
EPS Growth | 7.30% | 5.62% | -11.09% | 111.85% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 3.42 | 3.32 | 17.43 | 20.53 | 19.25 |
Free Cash Flow Per Share | - | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 |
Dividend Per Share | 0.025 | 0.015 | 0.013 | 0.013 | - | - |
Dividend Growth | 98.44% | 20.31% | 0% | - | - | - |
Gross Margin | 68.60% | 67.85% | 69.76% | 69.22% | 67.57% | 69.70% |
Operating Margin | 23.10% | 21.80% | 21.22% | 25.58% | 17.46% | 17.58% |
Profit Margin | 22.33% | 23.22% | 24.20% | 29.29% | 13.51% | -3.82% |
Free Cash Flow Margin | - | 1.89% | 2.02% | 11.33% | 15.01% | 16.53% |
EBITDA | 48.53 | 42.78 | 37.59 | 41.3 | 25.84 | 22.86 |
EBITDA Margin | 24.81% | 23.71% | 22.91% | 26.84% | 18.89% | 19.63% |
D&A For EBITDA | 3.35 | 3.44 | 2.77 | 1.94 | 1.95 | 2.39 |
EBIT | 45.18 | 39.34 | 34.82 | 39.36 | 23.89 | 20.48 |
EBIT Margin | 23.10% | 21.80% | 21.22% | 25.58% | 17.46% | 17.58% |
Effective Tax Rate | 13.29% | 10.73% | 6.04% | 9.18% | 15.14% | - |